Due to the rapid pace of research in gastrointestinal malignancies, community oncology physicians often face difficulty synthesizing emerging and evolving data into routine patient care. The purpose of this 1-day symposium is to provide participants with expert insights from leading investigators in treatment selection and supportive care best practices for patients with colorectal cancer, hepatocellular carcinoma, gastric cancer, pancreatic cancer, esophageal cancer, gastrointestinal stromal tumor, biliary tract cancers, and neuroendocrine tumors.

Upon completion of this activity, participants should be able to:

• Describe biomarkers that affect treatment selection for patients with gastrointestinal malignancies
• Differentiate current and emerging efficacy and safety data on novel therapies for gastrointestinal malignancies
• Asses multidisciplinary approaches in treatment planning for patients with gastrointestinal malignancies
• Evaluate supportive care plans for patients with gastrointestinal malignancies

Learning objectives apply to all professions in the target audience.

Medical oncologists, surgical oncologists, radiation oncologists, oncology advanced practitioners, oncology nurses, and other health care professionals involved in the treatment of patients with gastrointestinal malignancies.

Click here to view the schedule.

Register by March 1, 2016 to receive 25% off.  For more information about fees, click here.

Please click here to register or give us a call at 855-276-6855.

Jointly Provided By

PHYSICIANS

USF Health designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES

USF Health is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

A maximum of 8.5 contact hours may be earned by learners who successfully complete this continuing nursing education activity.